Summary
- Current Price
- As of today, AXSM price is $213.67, unchanged in the most recent trading session on
- Current Price All-Time High
- AXSM price is currently -17.88% below its historical high of $260.19 set on
- Market Cap
- AXSM current market cap is $11B, up +106.60% over the past 365 days
- Revenue
- AXSM current annual revenue is $638.50M, up +65.55% year-over-year
- Next Earnings
- As of today, the next earnings release for AXSM has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Axsome Therapeutics, Inc. |
| Ticker | NASDAQ: AXSM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | axsome.com |
| Employees | 712 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $213.67 | |
| Price, 1D Change | 0.00% | |
| Market Cap | $11B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.55 | |
| Revenue | $638.50M | |
| Revenue, 1Y Change | +65.55% | |
| EPS | -$3.68 | |
| EPS, 1Y Change | +38.57% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$3.68 | |
| EPS Estimate | -$2.49 | N/A |
| EPS Est. Change | +32.44% | N/A |
| Revenue | $638.50M | |
| Revenue Estimate | $974.07M | N/A |
| Revenue Est. Change | +52.56% | N/A |
| Current Price | $213.67 | |
| Price Target | $276.00 | - |
| Price Tgt. Change | +29.17% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.15 | -$5.99 | -16.40% | |
| -$3.87 | -$3.68 | +4.84% | |
| -$2.49 | N/A | +32.44% | |
| $5.59 | N/A | +251.82% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $385.06M | $385.69M | +0.16% | |
| $635.84M | $638.50M | +0.42% | |
| $974.07M | N/A | +52.56% | |
| $1.57B | N/A | +146.14% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +96.48% | |
| Price, 3Y | +198.21% | |
| Market Cap, 1Y | +106.60% | |
| Market Cap, 3Y | +234.30% | |
| Revenue, 1Y | +65.55% | |
| Revenue, 3Y | +1,176.05% | |
| EPS, 1Y | +38.57% | |
| EPS, 3Y | +20.00% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $213.67 | |
| SMA 200 | $189.05 | |
| SMA 50 | $235.26 | |
| EMA 200 | $193.46 | |
| EMA 50 | $226.32 | |
| MACD | -$6.38 | |
| Beta | 0.55 | |
| ATR | $9.17 | |
| 14-Day RSI | 40.35 | |
| 10-Day Volatility | 47.04% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $638.50M | |
| EPS | -$3.68 | |
| Gross Profit | $581.95M | |
| Gross Margin | 91.14% | |
| Operating Income | -$169.24M | |
| Operating Margin | -26.51% | |
| Net Income | -$183.17M | |
| Net Margin | -28.69% | |
| EBITDA | -$160.17M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 2.47 | |
| 1.55 | ||
| 1.48 | ||
| - | ||
| 3 | ||
| 9.00 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 15.80 | ||
| 205.03 | ||
| -66.37 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $88.29M | |
| $322.93M | ||
| $689.81M | ||
| $588.99M | ||
| $601.51M | ||
| $378.84M | ||
| Total Debt | $218.11M | |
| $72.98M | ||
| $65.54M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $821.67M | ||
| $751.19M | ||
| $56.54M | ||
| $0.00 | ||
| $9.06M | ||
| $0.00 | ||
| -$530.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$93.41M | ||
| -$480.00K | ||
| $101.47M | ||
| Capex | $480.00K | |
| -$93.89M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Mizuho | → | |
| Wells Fargo | → | |
| RBC Capital | → | |
| Needham | → | |
| Morgan Stanley | → | |
| Guggenheim | → | |
| Mizuho | → | |
| BMO Capital | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with AXSM
FAQ
- What is the ticker symbol for Axsome Therapeutics, Inc.?
- The ticker symbol for Axsome Therapeutics, Inc. is NASDAQ:AXSM
- Does Axsome Therapeutics, Inc. pay dividends?
- No, Axsome Therapeutics, Inc. does not pay dividends
- What sector is Axsome Therapeutics, Inc. in?
- Axsome Therapeutics, Inc. is in the Healthcare sector
- What industry is Axsome Therapeutics, Inc. in?
- Axsome Therapeutics, Inc. is in the Biotechnology industry
- What country is Axsome Therapeutics, Inc. based in?
- Axsome Therapeutics, Inc. is headquartered in United States
- When did Axsome Therapeutics, Inc. go public?
- Axsome Therapeutics, Inc. initial public offering (IPO) was on November 19, 2015
- Is Axsome Therapeutics, Inc. in the S&P 500?
- No, Axsome Therapeutics, Inc. is not included in the S&P 500 index
- Is Axsome Therapeutics, Inc. in the NASDAQ 100?
- No, Axsome Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Axsome Therapeutics, Inc. in the Dow Jones?
- No, Axsome Therapeutics, Inc. is not included in the Dow Jones index
- When was Axsome Therapeutics, Inc. last earnings report?
- Axsome Therapeutics, Inc.'s most recent earnings report was on August 10, 2026
- When does Axsome Therapeutics, Inc. report earnings?
- The date for Axsome Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- AXSM Official Website www.axsome.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1579428/000119312526064267/0001193125-26-064267-index.htm
- AXSM Profile on Yahoo Finance finance.yahoo.com/quote/AXSM
- AXSM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/axsm